The agent-first developer toolchain: how AI will radically transform the SDLC

Eliminating drug toxicity with AI: our investment in Axiom

Axiom is going to completely transform the multi-billion dollar market for drug toxicity testing.

How SkipLabs is building React for the backend

Annotation for AI doesn’t Scale

As models get more and more capable, the systems we've built to label and annotate data aren't cutting it: what's going to replace them?

Welcoming Arjun Narayan as Amplify's newest Venture Partner

We're excited to announce that Arjun is joining Amplify as a Venture Partner based out of NYC.

Git With It: BYOC Panel

A conversation with 3 leaders in databases about BYOC and whether / how startups should support it.

Amplify 2024 Lookback

2024 was an amazing year for Amplify, and here are some highlights.

NeurIPS 2024: main themes and takeaways

Our takeaways, from advances in data curation to compute scaling laws and (finally) good audio models coming soon.

Our Investment in Allium

We originally backed Allium in their seed round and are thrilled to invest in their Series A.

Let Your Documentation Do The Work: The Scribe Story

How Scribe’s documentation platform empowers employees to capture and share knowledge.

Our Investment in Effectful

Effectful is only the beginning of a movement that aims to redefine what’s possible for JS developers worldwide.